低危人群中脐静脉血流与胎儿生长异常及不良围产结局的关联:多中心前瞻性研究
这项多中心前瞻性观察研究纳入365例孕35至38周、单胎且估测体重适龄的低危孕妇,测量脐静脉血流并计算UVF/AC。严重生长迟缓与较低的UVF/AC相关,UVF/AC对严重生长迟缓和不良围产结局均有中等预测能力,排除能力中等而确诊能力差。
要点
- 低危孕妇孕晚期UVF/AC较低与严重胎儿生长迟缓相关。
- UVF/AC预测严重生长迟缓的AUC为0.65,最佳cut-off为7.2 mL/min/cm。
- UVF/AC预测不良围产结局的AUC为0.65,最佳cut-off为6.7 mL/min/cm。
核心结论
- 在低危孕妇队列中,接近足月时UVF降低与严重胎儿生长迟缓和不良围产结局相关。
- UVF/AC对两种结局的排除能力中等,确诊能力差。
- 需要进一步研究以确定评估UVF能否改善对亚临床胎盘功能不全和不良围产结局高危胎儿的识别。
研究设计与样本
- 多中心前瞻性观察性研究,在两个三级产科单位开展。
- 纳入孕35至38周、单胎、估测体重适龄的孕妇,排除胎盘功能不全较高风险或胎儿异常者。
- 2021年4月至2023年3月共纳入365名孕妇。
- 测量腹围、脐静脉直径和脐静脉峰值流速,计算UVF/AC。
主要发现
- 入组时平均UVF/AC为6.4 ± 2.6 mL/min/cm,35例(9.6%)发生严重胎儿生长迟缓。
- 严重胎儿生长迟缓组平均UVF/AC为5.4 ± 2.6 mL/min/cm,低于无严重生长迟缓组的6.5 ± 2.6 mL/min/cm(P = 0.02)。
- 严重胎儿生长迟缓组UVF/AC低于第10百分位的频率为8/35(22.9%),高于无严重生长迟缓组的28/330(8.5%)(P = 0.01)。
- 不良围产结局与母亲年龄(aOR 0.93,95% CI 0.87-0.99;P = 0.04)、UVF/AC Z评分(aOR 0.53,95% CI 0.30-0.87;P = 0.01)和产程加强(aOR 2.69,95% CI 1.28-5.69;P = 0.009)独立相关。
关键数值与推荐
- UVF/AC预测严重胎儿生长迟缓的AUC为0.65(95% CI 0.55-0.75;P = 0.004),最佳cut-off为7.2 mL/min/cm。
- cut-off 7.2 mL/min/cm预测严重胎儿生长迟缓的敏感度为0.77(95% CI 0.60-0.90),特异度为0.33(95% CI 0.28-0.39),阳性预测值为0.11(95% CI 0.07-0.15),阴性预测值为0.93(95% CI 0.87-0.97)。
- UVF/AC预测不良围产结局的AUC为0.65(95% CI 0.56-0.73;P = 0.005),最佳cut-off为6.7 mL/min/cm。
- cut-off 6.7 mL/min/cm预测不良围产结局的敏感度为0.70(95% CI 0.54-0.83),特异度为0.40(95% CI 0.34-0.45),阳性预测值为0.14(95% CI 0.09-0.19),阴性预测值为0.91(95% CI 0.85-0.95)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步研究以确定评估UVF能否改善对亚临床胎盘功能不全和不良围产结局高危胎儿的识别。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the relationship of umbilical vein flow (UVF) measured close to term with abnormal fetal growth and adverse perinatal outcome in a cohort of pregnancies at low risk of placental insufficiency. METHODS: This was a prospective multicenter observational study conducted across two tertiary maternity units. Patients with a singleton appropriate-for-gestational-age fetus between 35 and 38 weeks' gestation were included. Pregnancies at higher risk of placental insufficiency or with fetal anomalies were excluded. At ultrasound examination, the abdominal circumference (AC), umbilical vein diameter and peak velocity of the umbilical vein were measured, and, using these variables, a new variable, UVF/AC, was calculated. The primary outcome was the occurrence of severely stunted fetal growth, defined as a greater than 40-percentile drop between estimated fetal weight at the third-trimester ultrasound and birth weight. The occurrence of adverse perinatal outcome (defined as one of the following: neonatal acidosis (umbilical artery pH < 7.15 and/or base excess > 12 mmol/L) at birth, 5-min Apgar score < 7, neonatal resuscitation or neonatal intensive care unit admission) was analyzed as a secondary outcome. RESULTS: Between April 2021 and March 2023, 365 women were included in the study. The mean UVF/AC at enrolment was 6.4 ± 2.6 mL/min/cm, and 35 (9.6%) cases were affected by severely stunted fetal growth. Severely stunted fetal growth was associated with a lower mean UVF/AC (5.4 ± 2.6 vs 6.5 ± 2.6 mL/min/cm; P = 0.02) and a higher frequency of UVF/AC < 10th percentile (8/35 (22.9%) vs 28/330 (8.5%); P = 0.01). Moreover, UVF/AC showed an area under the receiver-operating-characteristics curve (AUC) of 0.65 (95% CI, 0.55-0.75; P = 0.004) in predicting the occurrence of severely stunted fetal growth, and the optimal cut-off value of UVF/AC for discriminating between normal and severely stunted fetal growth was 7.2 mL/min/cm. This value was associated with a sensitivity and specificity of 0.77 (95% CI, 0.60-0.90) and 0.33 (95% CI, 0.28-0.39), and positive and negative predictive values of 0.11 (95% CI, 0.07-0.15) and 0.93 (95% CI, 0.87-0.97), respectively. Regarding the occurrence of adverse perinatal outcome, this was associated independently with maternal age (adjusted odds ratio (aOR), 0.93 (95% CI, 0.87-0.99); P = 0.04), UVF/AC Z-score (aOR, 0.53 (95% CI, 0.30-0.87); P = 0.01) and augmentation of labor (aOR, 2.69 (95% CI, 1.28-5.69); P = 0.009). UVF/AC showed an AUC of 0.65 (95% CI, 0.56-0.73; P = 0.005) in predicting the occurrence of adverse perinatal outcome, and the optimal cut-off value of UVF/AC for discriminating between normal and adverse perinatal outcome was 6.7 mL/min/cm. This value was associated with a sensitivity and specificity of 0.70 (95% CI, 0.54-0.83) and 0.40 (95% CI, 0.34-0.45), and positive and negative predictive values of 0.14 (95% CI, 0.09-0.19) and 0.91 (95% CI, 0.85-0.95), respectively. CONCLUSIONS: Our data demonstrate an association between reduced UVF close to term, severely stunted fetal growth and adverse perinatal outcome in a cohort of low-risk pregnant women, with a moderate ability to rule out and a poor ability to rule in either outcome. Further studies are needed to establish whether the assessment of UVF can improve the identification of fetuses at risk of subclinical placental insufficiency and adverse perinatal outcome. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Ramirez Zegarra R, Carbone IF, Angeli L, et al. Association of umbilical vein flow with abnormal fetal growth and adverse perinatal outcome in low-risk population: multicenter prospective study. Ultrasound Obstet Gynecol. 2024. PMID: 37963279. doi:10.1002/uog.27534
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。